NEULAND LABORATORIES
|
The Current P/S Ratio of NEULAND LABORATORIES is 12.62.
| Share Price | ₹15,119.2 | Jan 01,2026 |
| Market Cap | ₹19,352.6 Cr | |
| Sales-TTM | ₹1,533.4 Cr | TTM-Consolidated Results |
| Price/Sales | 12.62x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,352.6 Cr] as on Jan 01,2026
(/) Sales [ ₹1,533.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.62x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '12.62 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !
The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES
PS Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.37x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 2.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 10.49x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.38x.
How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| NEULAND LABORATORIES | 1,533.4 | 12.62 | 19,352.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.51 | 412,782.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.79 | 168,376.0 |
| CIPLA LTD | 28,349.6 | 4.27 | 121,174.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.63 | 130,225.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.05 | 104,629.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.58 | 89,293.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.76 | 92,020.1 |
| LUPIN LTD | 24,750.7 | 3.88 | 96,078.5 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.13 | 69,283.8 |
| ABBOTT INDIA LTD | 6,714.4 | 9.02 | 60,531.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.13x |
| Max industry PS | 16.79x |
| Median industry PS | 6.58x |
| Average industry PS | 7.29x |
You may also like the below Video Courses